Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Schietinger

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Oncoimmunology|November 20, 2012
A sensitivity scale for targeting T cells with chimeric antigen receptors (CARs) and bispecific T-cell Engagers (BiTEs)Jennifer D Stone, David H Aggen, Andrea Schietinger, et al.
Science (New York, N.Y.)|January 24, 2012
Rescued tolerant CD8 T cells are preprogrammed to reestablish the tolerant stateAndrea Schietinger, Jeffrey J Delrow, Ryan S Basom, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2013
IL-15 in tumor microenvironment causes rejection of large established tumors by T cells in a noncognate T cell receptor-dependent mannerRebecca Berlant Liu, Boris Engels, Karin Schreiber, et al.
Science (New York, N.Y.)|October 14, 2006
A mutant chaperone converts a wild-type protein into a tumor-specific antigenAndrea Schietinger, Mary Philip, Barbara A Yoshida, et al.
Nature Immunology|February 27, 2026
TOX drives CD4<sup>+</sup> T<sub>H</sub>1 effector function, antitumor immunity and autoimmune pathologyBrianna Naizir, Andrew C Scott, Paul Zumbo, et al.
Elife|December 1, 2018
Rejection of immunogenic tumor clones is limited by clonal fractionRon S Gejman, Aaron Y Chang, Heather F Jones, et al.
Cancer Research|March 5, 2008
Equilibrium between host and cancer caused by effector T cells killing tumor stromaBin Zhang, Yi Zhang, Natalie A Bowerman, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
Intratumoral immune triads are required for adoptive T cell therapy-mediated elimination of solid tumorsGabriel Espinosa-Carrasco, Aurora Scrivo, Paul Zumbo, et al.
Nature Immunology|January 6, 2004
Priming of naive T cells inside tumors leads to eradication of established tumorsPing Yu, Youjin Lee, Wenhua Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 18, 2012
Cell-intrinsic abrogation of TGF-β signaling delays but does not prevent dysfunction of self/tumor-specific CD8 T cells in a murine model of autochthonous prostate cancerCassie K Chou, Andrea Schietinger, H Denny Liggitt, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Oncoimmunology|November 20, 2012
A sensitivity scale for targeting T cells with chimeric antigen receptors (CARs) and bispecific T-cell Engagers (BiTEs)Jennifer D Stone, David H Aggen, Andrea Schietinger, et al.
Science (New York, N.Y.)|January 24, 2012
Rescued tolerant CD8 T cells are preprogrammed to reestablish the tolerant stateAndrea Schietinger, Jeffrey J Delrow, Ryan S Basom, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2013
IL-15 in tumor microenvironment causes rejection of large established tumors by T cells in a noncognate T cell receptor-dependent mannerRebecca Berlant Liu, Boris Engels, Karin Schreiber, et al.
Science (New York, N.Y.)|October 14, 2006
A mutant chaperone converts a wild-type protein into a tumor-specific antigenAndrea Schietinger, Mary Philip, Barbara A Yoshida, et al.
Nature Immunology|February 27, 2026
TOX drives CD4<sup>+</sup> T<sub>H</sub>1 effector function, antitumor immunity and autoimmune pathologyBrianna Naizir, Andrew C Scott, Paul Zumbo, et al.
Elife|December 1, 2018
Rejection of immunogenic tumor clones is limited by clonal fractionRon S Gejman, Aaron Y Chang, Heather F Jones, et al.
Cancer Research|March 5, 2008
Equilibrium between host and cancer caused by effector T cells killing tumor stromaBin Zhang, Yi Zhang, Natalie A Bowerman, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
Intratumoral immune triads are required for adoptive T cell therapy-mediated elimination of solid tumorsGabriel Espinosa-Carrasco, Aurora Scrivo, Paul Zumbo, et al.
Nature Immunology|January 6, 2004
Priming of naive T cells inside tumors leads to eradication of established tumorsPing Yu, Youjin Lee, Wenhua Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 18, 2012
Cell-intrinsic abrogation of TGF-β signaling delays but does not prevent dysfunction of self/tumor-specific CD8 T cells in a murine model of autochthonous prostate cancerCassie K Chou, Andrea Schietinger, H Denny Liggitt, et al.
Pageof 5